Condition
Primary CNS Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Primary CNS Lymphoma clinical trials that are recruiting, at sites in 5 countries (most in South Korea (1), Taiwan (1), Italy (1)). By phase: Phase 2 (1), Phase 4 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 5Countries
Newest Primary CNS Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Treatment protocol for B-cell mature non-Hodgkin's lymphoma in children and adolescents | Phase 4 | Moscow, RF | Recruiting | Aug 26, 2022 |
| CSF DNA testing to improve diagnosis and monitoring in primary CNS lymphoma | — | Milan, Italy/Lombardy | Recruiting | Sep 5, 2021 |
| Using advanced MRI to detect primary CNS lymphoma | Phase 1 | San Francisco, California | Recruiting | Dec 7, 2020 |
| Lenalidomide and Rituximab for Patients with Primary CNS Lymphoma Who Can't Have Transplants | Phase 2 | Seoul | Recruiting | Nov 13, 2020 |
| Evaluating neurobehavioral functions in newly diagnosed primary CNS lymphoma patients receiving advanced radiation therapy | — | Taoyuan | Recruiting | Jul 5, 2019 |
All recruiting trials (5)
-
Treatment protocol for B-cell mature non-Hodgkin's lymphoma in children and adolescents
This study is testing different treatment plans for children and teenagers with B-cell non-Hodgkin's lymphoma to see who needs stronger therapy and who can safely have gentler options.
-
CSF DNA testing to improve diagnosis and monitoring in primary CNS lymphoma
This project will test whether sequencing DNA from spinal fluid can help diagnose and monitor people with suspected or confirmed primary CNS lymphoma.
-
Using advanced MRI to detect primary CNS lymphoma
This study is testing a new type of MRI to see if it can help doctors better detect and monitor primary central nervous system lymphoma in patients.
-
Lenalidomide and Rituximab for Patients with Primary CNS Lymphoma Who Can't Have Transplants
This study is testing if a combination of two medications, lenalidomide and rituximab, can help older patients or those in poor health with primary CNS lymphoma who can't have a stem cell transplant stay healthy longer after their initial treatment.
-
Evaluating neurobehavioral functions in newly diagnosed primary CNS lymphoma patients receiving advanced radiation therapy
This study is testing a new radiation therapy for people newly diagnosed with primary CNS lymphoma to see if it can control the tumor while also helping to protect their thinking and memory skills.
Related topics
Quick answers
How many Primary CNS Lymphoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in South Korea (1 trial), Taiwan (1 trial), Italy (1 trial), Russia (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 4: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.